Interpreting score differences in the SF-36 Vitality scale: Using clinical conditions and functional outcomes to define the minimally important difference

Current Medical Research and Opinion

Volumn 23, Issue 4, 2007, Pages 731-739

  Bjorner, Jakob B ^a   Wallenstein, Gene V ^a   Martin, Marie C ^a   Lin, Peggy ^a   Blaisdell Gross, Bonnie ^a   Piech, Catherine Tak ^b   Mody, Samir H ^b  

^a QualityMetric Incorporated   (United States)

^b Ortho Biotech Products LP   (United States)

Author keywords

Anemia; Fatigue; MCID; MID; SF 36 Vitality scale

Indexed keywords

ANEMIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FATIGUE; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; SHORT FORM 36; UNEMPLOYMENT;

AGED; AGED, 80 AND OVER; ALGORITHMS; CHRONIC DISEASE; DECISION SUPPORT TECHNIQUES; FATIGUE; FEMALE; HOSPITALIZATION; HUMANS; JOB SATISFACTION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RESEARCH DESIGN;

EID: 34247334563     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X178757     Document Type: Article

References (27)

1. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989:10;407-15
2. Guyatt GH, Osoba D, Wu AW, et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002:77;371-83
3. Guidance for industry - patient-reported outcome measures: use in medical product development to support labeling claims (draft guidance). Rockville (MD): Food and Drug Administration; 2006 (http://www.fda.gov/cder/guidance/ 5460dft.htm)
4. McHorney CA, Ware Jr JE, Lu JF, et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994:32;40-66
5. McHorney CA, Ware Jr JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993:31;247-63
6. Ware Jr JE, Snow KK, Kosinski M, et al. SF-36 Health Survey. Manual and interpretation guide. Boston: The Health institute, New England Medical Center; 1993
7. Ware Jr JE, Kosinski M, Keller SD. SF-36 physical and mental healdi summary scales - a user's manual. Boston: The Health Institute; 1994
8. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. New Engl J Med 1986:314;1657-64
9. Fowler FJ, Wennberg JE, Timothy RP, et al. Symptom status and quality of life following prostatectomy. J Am Med Assoc 1988:259;3018-22
10. Wachtel T, Piette J, Mor V, et al. Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med 1992:116;129-37
11. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients widi chronic conditions. Results from the Medical Outcomes Study. J Am Med Assoc 1989:262;907-13
12. Ware Jr JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992:30;473-83
13. Greenfield S, Rogers W, Mangotich M, et al. Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and specialties. Results from the Medical Outcomes Study. J Am Med Assoc 1995:274;1436-44
14. Lin DY, Wei LJ, Ying Z. Checking the Cox model with cumulative sums of Martingale-based residuals. Biometrica 1993:80;557-72
15. Ware Jr JE, Kosinski M, Dewey J. How to score version two of the SF-36 Health Survey. Lincoln (RI): QualityMetric Inc.; 2000
16. Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 2000:18;419-23
17. Crosby RD, Kolotkin RL, Williams GR. An integrated method to determine meaningful changes in health-related quality of life. J Clin Epidemiol 2004:57;1153-60
18. Spiegel BM, Younossi ZM, Hays RD, et al. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 2005:41;790-800
19. Wyrwich KW, Nienaber NA, Tierney WM, et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999:37;469-78
20. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999:52;861-73
21. Cohen J. Statistical power for the behavioral sciences. Hillsdale (NT): Erlbaum; 1988
22. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003:41;582-92
23. Kosinski M, Zhao SZ, Dedhiya S, et al. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000:43,1478-87
24. Wyrwich KW, Fihn SD, Tierney WM, et al. Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: an expert consensus panel report. J Gen Intern Med 2003:18;196-202
25. Wyrwich KW, Spertus JA, Kroenke K, et al. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. Am Heart J 2004:147;615-22
26. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003:56;395-407
27. Cella D, Hahn EA, Dineen K. Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res 2002:11;207-21